O	0	10	Randomized
O	11	16	trial
O	17	19	of
B-intervention	20	29	proactive
I-intervention	30	35	rapid
I-intervention	36	43	genetic
I-intervention	44	54	counseling
O	55	61	versus
B-control	62	67	usual
I-control	68	72	care
O	73	76	for
O	77	82	newly
O	83	92	diagnosed
O	93	99	breast
O	100	106	cancer
O	107	115	patients
O	115	116	.

O	117	123	Breast
O	124	130	cancer
O	131	139	patients
O	140	143	who
O	144	149	carry
O	150	155	BRCA1
O	155	156	/
O	156	161	BRCA2
O	162	166	gene
O	167	176	mutations
O	177	180	may
O	181	189	consider
O	190	199	bilateral
O	200	210	mastectomy
O	210	211	.

O	212	218	Having
O	219	228	bilateral
O	229	239	mastectomy
O	240	242	at
O	243	246	the
O	247	251	time
O	252	254	of
O	255	264	diagnosis
O	265	268	not
O	269	273	only
O	274	281	reduces
O	282	286	risk
O	287	289	of
O	290	291	a
O	292	305	contralateral
O	306	312	breast
O	313	319	cancer
O	319	320	,
O	321	324	but
O	325	328	can
O	329	338	eliminate
O	339	342	the
O	343	347	need
O	348	351	for
O	352	361	radiation
O	362	369	therapy
O	370	373	and
O	374	379	yield
O	380	388	improved
O	389	403	reconstruction
O	404	411	options
O	411	412	.

O	413	420	However
O	420	421	,
O	422	426	most
O	427	435	patients
O	436	438	do
O	439	442	not
O	443	450	receive
O	451	458	genetic
O	459	469	counseling
O	470	472	or
O	473	480	testing
O	481	483	at
O	484	487	the
O	488	492	time
O	493	495	of
O	496	501	their
O	502	511	diagnosis
O	511	512	.

O	513	515	In
O	516	520	this
O	521	526	trial
O	526	527	,
O	528	530	we
O	531	537	tested
O	538	547	proactive
O	548	553	rapid
O	554	561	genetic
O	562	572	counseling
O	573	576	and
O	577	584	testing
O	585	586	(
O	586	590	RGCT
O	590	591	)
O	592	594	in
B-eligibility	595	600	newly
I-eligibility	601	610	diagnosed
I-eligibility	611	617	breast
I-eligibility	618	624	cancer
I-eligibility	625	633	patients
O	634	636	in
O	637	642	order
O	643	645	to
O	646	656	facilitate
O	657	660	pre
O	660	661	-
O	661	669	surgical
O	670	677	genetic
O	678	688	counseling
O	689	692	and
O	693	700	testing
O	700	701	.

O	702	704	We
O	705	714	recruited
O	715	720	newly
O	721	730	diagnosed
O	731	737	breast
O	738	744	cancer
O	745	753	patients
O	754	756	at
O	757	766	increased
O	767	771	risk
O	772	775	for
O	776	784	carrying
O	785	786	a
O	787	792	BRCA1
O	792	793	/
O	793	794	2
O	795	803	mutation
O	803	804	.

O	805	807	Of
B-total-participants	808	811	379
O	812	820	eligible
O	821	829	patients
O	830	833	who
O	834	843	completed
O	844	845	a
O	846	854	baseline
O	855	861	survey
O	861	862	,
B-total-participants	863	866	330
O	867	873	agreed
O	874	876	to
O	877	890	randomization
O	891	893	in
O	894	895	a
O	896	897	2
O	897	898	:
O	898	899	1
O	900	905	ratio
O	906	908	to
O	909	913	RGCT
O	914	915	(
O	915	916	n
O	917	918	=
B-intervention-participants	919	922	220
O	922	923	)
O	924	930	versus
O	931	933	UC
O	934	935	(
O	935	936	n
O	937	938	=
B-control-participants	939	942	108
O	942	943	)
O	943	944	.

O	945	952	Primary
O	953	961	outcomes
O	962	966	were
B-outcome-Measure	967	974	genetic
I-outcome-Measure	975	985	counseling
I-outcome-Measure	986	989	and
I-outcome-Measure	990	997	testing
I-outcome-Measure	998	1004	uptake
O	1005	1008	and
B-outcome-Measure	1009	1015	breast
I-outcome-Measure	1016	1022	cancer
I-outcome-Measure	1023	1031	surgical
I-outcome-Measure	1032	1041	decisions
O	1041	1042	.

O	1043	1047	RGCT
O	1048	1051	led
O	1052	1054	to
O	1055	1061	higher
B-outcome	1062	1069	overall
O	1070	1071	(
B-iv-bin-percent	1071	1073	83
I-iv-bin-percent	1073	1074	.
I-iv-bin-percent	1074	1075	8
I-iv-bin-percent	1075	1076	%
O	1077	1079	vs
O	1079	1080	.
B-cv-bin-percent	1081	1083	54
I-cv-bin-percent	1083	1084	.
I-cv-bin-percent	1084	1085	6
I-cv-bin-percent	1085	1086	%
O	1086	1087	;
O	1088	1089	p
O	1090	1091	<
O	1092	1093	0
O	1093	1094	.
O	1094	1098	0001
O	1098	1099	)
O	1100	1103	and
B-outcome	1104	1107	pre
I-outcome	1107	1108	-
I-outcome	1108	1116	surgical
O	1117	1118	(
B-iv-bin-percent	1118	1120	57
I-iv-bin-percent	1120	1121	.
I-iv-bin-percent	1121	1122	8
I-iv-bin-percent	1122	1123	%
O	1124	1126	vs
O	1126	1127	.
B-cv-bin-percent	1128	1130	38
I-cv-bin-percent	1130	1131	.
I-cv-bin-percent	1131	1132	7
I-cv-bin-percent	1132	1133	%
O	1133	1134	;
O	1135	1136	p
O	1137	1138	=
O	1139	1140	0
O	1140	1141	.
O	1141	1144	001
O	1144	1145	)
B-outcome	1146	1153	genetic
I-outcome	1154	1164	counseling
I-outcome	1165	1171	uptake
O	1172	1180	compared
O	1181	1183	to
O	1184	1186	UC
O	1186	1187	.

O	1188	1195	Despite
O	1196	1202	higher
O	1203	1208	rates
O	1209	1211	of
O	1212	1219	genetic
O	1220	1230	counseling
O	1230	1231	,
O	1232	1236	RGCT
O	1237	1240	did
O	1241	1244	not
O	1245	1251	differ
O	1252	1256	from
O	1257	1259	UC
O	1260	1262	in
B-outcome	1263	1270	overall
O	1271	1272	(
B-iv-bin-percent	1272	1274	54
I-iv-bin-percent	1274	1275	.
I-iv-bin-percent	1275	1276	1
I-iv-bin-percent	1276	1277	%
O	1278	1280	vs
O	1280	1281	.
B-cv-bin-percent	1282	1284	49
I-cv-bin-percent	1284	1285	.
I-cv-bin-percent	1285	1286	1
I-cv-bin-percent	1286	1287	%
O	1287	1288	,
O	1289	1290	p
O	1291	1292	>
O	1293	1294	0
O	1294	1295	.
O	1295	1297	10
O	1297	1298	)
O	1299	1301	or
B-outcome	1302	1305	pre
I-outcome	1305	1306	-
I-outcome	1306	1314	surgical
O	1315	1316	(
B-iv-bin-percent	1316	1318	30
I-iv-bin-percent	1318	1319	.
I-iv-bin-percent	1319	1320	6
I-iv-bin-percent	1320	1321	%
O	1322	1324	vs
O	1324	1325	.
B-cv-bin-percent	1326	1328	27
I-cv-bin-percent	1328	1329	.
I-cv-bin-percent	1329	1330	4
I-cv-bin-percent	1330	1331	%
O	1331	1332	,
O	1333	1334	p
O	1335	1336	>
O	1337	1338	0
O	1338	1339	.
O	1339	1341	10
O	1341	1342	)
B-outcome	1343	1350	receipt
I-outcome	1351	1353	of
I-outcome	1354	1361	genetic
I-outcome	1362	1366	test
I-outcome	1367	1374	results
O	1375	1378	nor
O	1379	1382	did
O	1383	1387	they
O	1388	1394	differ
O	1395	1397	in
B-outcome	1398	1404	uptake
I-outcome	1405	1407	of
I-outcome	1408	1417	bilateral
I-outcome	1418	1428	mastectomy
O	1429	1430	(
B-iv-bin-percent	1430	1432	26
I-iv-bin-percent	1432	1433	.
I-iv-bin-percent	1433	1434	6
I-iv-bin-percent	1434	1435	%
O	1436	1438	vs
O	1438	1439	.
B-cv-bin-percent	1440	1442	21
I-cv-bin-percent	1442	1443	.
I-cv-bin-percent	1443	1444	8
I-cv-bin-percent	1444	1445	%
O	1445	1446	,
O	1447	1448	p
O	1449	1450	>
O	1451	1452	0
O	1452	1453	.
O	1453	1455	10
O	1455	1456	)
O	1456	1457	.

O	1458	1466	Although
O	1467	1471	RGCT
O	1472	1479	yielded
O	1480	1489	increased
O	1490	1497	genetic
O	1498	1508	counseling
O	1509	1522	participation
O	1522	1523	,
O	1524	1528	this
O	1529	1532	did
O	1533	1536	not
O	1537	1543	result
O	1544	1546	in
O	1547	1556	increased
O	1557	1562	rates
O	1563	1565	of
O	1566	1569	pre
O	1569	1570	-
O	1570	1578	surgical
O	1579	1586	genetic
O	1587	1594	testing
O	1595	1597	or
O	1598	1604	impact
O	1605	1613	surgical
O	1614	1623	decisions
O	1623	1624	.

O	1625	1630	These
O	1631	1635	data
O	1636	1643	suggest
O	1644	1648	that
O	1649	1654	those
O	1655	1663	patients
O	1664	1668	most
O	1669	1675	likely
O	1676	1678	to
O	1679	1682	opt
O	1683	1686	for
O	1687	1694	genetic
O	1695	1702	testing
O	1703	1705	at
O	1706	1709	the
O	1710	1714	time
O	1715	1717	of
O	1718	1727	diagnosis
O	1728	1731	are
O	1732	1737	being
O	1738	1749	effectively
O	1750	1760	identified
O	1761	1763	by
O	1764	1769	their
O	1770	1778	surgeons
O	1778	1779	.
